Jason P. Kirkness, Ph.D., Senior Vice President of Medical and Clinical Affairs at 4DMedical
Jun 16, 2023
Get to know Jason P. Kirkness, who works in Woodland Hills, California.
New York City, New York Jun 15, 2023 (Issuewire.com) - Jason is a clinical science executive and physiologist with leadership in novel medical device research, development, and commercialization. Joining 4DMedical in June 2020, his training, experience, and passion have positioned him to the role of Senior Vice President of Medical and Clinical Affairs.
One of the most critical health challenges over the next decade will be to access, manage, and utilize big data in order to discover sustainable improvements in quality of life. This effort requires tremendous coordination, teamwork, innovation, and creativity. The focus of Jason's career has been on novel technology, biological instrumentation, practice change, and the implementation of diagnostic and therapeutics for chronic diseases in children and adults.
4DMedical (formerly known as 4Dx) is a global medical technology company aiming to change the outcome for patients with lung disease by revolutionizing respiratory imaging and ventilation analysis.
With offices in Melbourne, Australia, and Los Angeles, California, 4D Medical has successfully proven and patented its XV Technology through years of studies and trials, completed by some of the most talented minds in medical technology.
"Our mission is to improve global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases" as stated on the company's website.
Initially educated at Western Sydney University, Jason graduated with his Bachelor's degree in Biology and his Bachelor's degree in Exercise and Respiratory Physiology (1st class honors) in 1996 and 1997, respectively.
Furthering his education, he completed his Doctor of Philosophy degree at the University of Sydney in 2003, and his post-doctoral fellowship at The Johns Hopkins University School of Medicine in 2006.
With over 20 years of training and experience in pulmonary physiology and sleep medicine, Jason was previously an Assistant Professor of Medicine at the Johns Hopkins School of Medicine, where his areas of investigation were novel technology, biological instrumentation, diagnostics, and therapies for chronic diseases. He has received research funding from the National Institutes of Health (NIH), the National Science Foundation (NSF), the American Heart Foundation, and the Australian National Health and Medical Research Council (NHMRC), among others.
An active, long-standing, and contributing member of the American Thoracic Society (ATS), Jason is on the ATS Drug Device Discovery and Development Committee. He is also an active member of the American College of Chest Physicians, the American Association of Respiratory Care, and the Society of Critical Care Medicine.
All in all, Jason strives to optimize healthcare resource allocation, improve patient outcomes, and evolve the business of medicine. He has authored more than 70 peer-reviewed publications, book chapters, and editorials, as well as patents in respiratory medicine.
Among his various accolades include I-Corps Technology Award (2016), American Heart Association National Career Development Award (2012), the Asia Pacific Society for Respirology Career Development Award (2008), and John Read Prize (2007, 1997), to name a.
Learn more about Jason P. Kirkness:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/85018012-Jason-Kirkness-Pulmonologist or through 4DMedical, https://4dmedical.com/about-4dmedical/our-team/
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey toward optimal health by providing you with the know-how to make informed decisions for you and your family.
Source :Jason P. Kirkness, Ph.D.
This article was originally published by IssueWire. Read the original article here.
More News
'My mortgage is going up £200 a month': How rising interest rates are hitting people's pockets
With UK interest rates set to rise, mortgages, credit cards and loans could get more expensive for millions.
Chinese vice premier holds video call with US officials
Chinese Vice Premier He Lifeng, also China's lead person for China-US economic and trade affairs, held a video call on Friday with US Treasury Secretary Scott Bessent and US Trade Representative Jamieson Greer.
Strong Hiring Reinforces a Sturdy Job Market
Unemployment fell in October, extending years of stability for a U.S. work force threatened by inflation and artificial intelligence.
Susie Wiles, Trump’s Chief of Staff, Is Accused of Blocking Health Policies to Attract Donations
In a no-holds-barred interview with Joe Rogan, Calley Means, a former top health adviser, accused Susie Wiles of repeatedly bowing to lobbying pressures and fixating on campaign contributions.
Elon Musk appears to signal the end of the road for Cybertruck
Musk said it was to make room for production of its Cybercabs - autonomous taxis without a driver.
Trump Appeals Dismissal of $10 Billion Libel Suit Against Wall Street Journal
A judge has twice tossed the president’s defamation complaint, which centered on an article about a birthday greeting to the sex offender Jeffrey Epstein.
AI stocks climb after trillions wiped from market values
Investors had been selling off tech shares in part due to concerns the Democrat election victory would mean slower AI development.
How Farmers’ Frustration With Trump’s Policies Helped Democrats
Anger over tariffs and higher costs because of the war in Iran led many Republican farmers and ranchers to vote blue — or stay home.
They Spent Millions to Keep Their Dream Cruise Afloat. It Died Anyway.
Secrecy, debt and soaring fuel costs all contributed to the Odyssey’s downfall. Here’s an inside look at how the “endless cruise” unraveled.
Why the US midterms sparked an AI stock selloff
Fears of more AI regulation appear to have sparked fear among investors, but concerns about the industry have been growing for some time.
Tesla Is Ending Production of Its Cybertruck and Refocusing on the Cybercab
Production of the electric trucks will stop in the middle of 2027 to make room for increased production of its autonomous ride-share vehicle, Elon Musk said.
Why smoky bacon crisps threaten to reignite rows over EU rules
A post-Brexit deal on food standards has raised questions over the future naming of the classic British snack.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.